STOCK TITAN

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Apellis Pharmaceuticals (Nasdaq: APLS) is set to participate in two major investor conferences in November 2021. The company will hold a fireside chat at the Credit Suisse 30th Annual Healthcare Conference on November 10 at 4:20 p.m. ET and a formal presentation at the Stifel Healthcare Conference on November 15 at 4:00 p.m. ET. Both events will be accessible via live webcast on the company’s website, with replays available for 90 days post-event. Apellis is a leader in targeted C3 therapies aimed at treating various serious diseases.

Positive
  • None.
Negative
  • None.

WALTHAM, Mass., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, today announced that the company will participate in the following investor conferences in November:

  • Credit Suisse 30th Annual Healthcare Conference: Fireside chat on Wednesday, November 10, 2021 at 4:20 p.m. ET.
  • Stifel Healthcare Conference: Formal presentation on Monday, November 15, 2021 at 4:00 p.m. ET.

The conference events will be available via live webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website. Replays of the webcasts will be available for 90 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in targeted C3 therapies, we aim to develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology. For more information, please visit www.apellis.com.

Investor Contact:
Meredith Kaya
meredith.kaya@apellis.com
617.599.8178


FAQ

What events will Apellis Pharmaceuticals participate in during November 2021?

Apellis Pharmaceuticals will participate in the Credit Suisse 30th Annual Healthcare Conference on November 10 and the Stifel Healthcare Conference on November 15, 2021.

What is the schedule for Apellis Pharmaceuticals at the Credit Suisse Healthcare Conference?

Apellis will have a fireside chat on November 10, 2021, at 4:20 p.m. ET.

When will the Stifel Healthcare Conference presentation occur for APLS?

Apellis Pharmaceuticals will present at the Stifel Healthcare Conference on November 15, 2021, at 4:00 p.m. ET.

How can I access the webcasts for Apellis Pharmaceuticals' conference events?

The webcasts for the conferences will be available on the 'Events and Presentations' page of the Investor and Media section of Apellis Pharmaceuticals' website.

How long will the conference webcasts from Apellis Pharmaceuticals be available?

The webcasts will be available for 90 days following the events.

Apellis Pharmaceuticals, Inc.

NASDAQ:APLS

APLS Rankings

APLS Latest News

APLS Stock Data

4.12B
105.50M
13.98%
99.97%
18.64%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
WALTHAM